ANSTO Publications Online >

Browsing by Subject Drugs

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
1-Feb-2010Analgesic ω-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native n-type calcium channels.Berecki, G; Motin, L; Haythornthwaite, A; Vink, S; Bansal, P; Drinkwater, R; Wang, CI; Moretta, M; Lewis, RJ; Alewood, PF; Christie, MJ; Adams, DJ
10-Sep-2009Discovery of [F-18]N-(2-(Diethylamino)ethyl)-6-fluoronicotinamide: a melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance.Greguric, I; Taylor, SR; Denoyer, D; Ballantyne, P; Berghofer, P; Roselt, P; Pham, TQ; Mattner, F; Bourdier, T; Neels, OC; Dorow, DS; Loc'h, C; Hicks, RJ; Katsifis, A
13-Oct-2009An investigation into the potential of SarAr for use in Cu-64 radioimmunotherapy.Di Bartolo, N; Smith, SV; Hetherington, E; Sargeson, A
1-May-2007Molecular imaging with copper-64 in the drug discovery and development arena.Smith, SV
7-Sep-2006New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr.Di Bartolo, N; Sargeson, AM; Smith, SV
4-May-2010Plasmonic nanorods provide reversible control over nanostructure of self-assembled drug delivery materials.Fong, WK; Hanley, TL; Thierry, B; Kirby, N; Boyd, BJ
Jun-1977Radioisotopes.Gregory, JN; Knight, RJ
11-Mar-2011Stabilization of Triam(m)inechloridoplatinum complexes by oxidation to PtIV.Daly, HL; Hall, MD; Failes, TW; Zhang, M; Foran, GJ; Hambley, TW
25-Jul-2005Technology evaluation: huN901-DM1 (ImmunoGen).Smith, SV
Showing results 1 to 9 of 9

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback